Navigation Links
Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
Date:4/14/2011

MISSISSAUGA, Ontario, April 14, 2011 /PRNewswire/ -- Theramed Corporation ("Theramed") announces that it has obtained the exclusive distribution rights in Canada for the EBB® Complete Tamponade System and the JETTY® Vaginal Repair Balloon, two newly developed medical devices used to advance the practice of obstetrics, from Glenveigh International, LLC ("Glenveigh").  [Both] medical device products have been approved for sale by Health Canada, and Theramed will begin distributing these products immediately.

About the EBB® Complete Tamponade System

EBB® is a complete tamponade solution for the emergency of postpartum hemorrhage.  Designed by world-renowned maternal-fetal medicine specialists Michael A. Belfort and Gary A. Dildy, the EBB® balloon is made of a malleable yet extremely strong material, allowing EBB to expand and conform to any uterine shape. Ebb also features a vaginal balloon to control vaginal bleeding and act as an anchor to support the uterine balloon. External ports allow independent control of inflation, deflation, irrigation, and drainage.

About the JETTY® Vaginal Repair Balloon

JETTY® is indicated for use during episiotomy and vaginal laceration repair to temporarily prevent the postpartum discharge of fluids from the vagina in order to assist with the repair procedure.  JETTY® provides clarity and cleanliness for a timely, effective repair, and it eliminates the need for vaginal packing with gauze or sponges.

About Theramed Corporation

Theramed Corporation, headquartered in Mississauga, Ontario, is a specialty pharmaceutical company, focused on the development, acquisition, in-licensing, marketing, and distribution of medical products in Canada. The Company is dedicated to bringing new-to-market and well-established healthcare innovations to Canadian Physicians and Hospitals, be these Pharmaceuticals, Biotech products, or Medical Devices. The company currently markets Delatestryl®, Viroptic®, CollatampG® and FSME IMMUNE®.

About Glenveigh International, LLC

Glenveigh International is the subsidiary of Glenveigh Medical LLC responsible for its ex-U.S. business. Glenveigh is a life science and medical technology company focused on advancing the practice of obstetrics, with aspirations to rapidly become the market leader in the OB/GYN field. Formed in 2004 by a maternal-fetal medicine (MFM) specialist, Glenveigh is founded on the core mission of improving the lives of pregnant mothers and their babies.

http://www.theramed.com


'/>"/>
SOURCE Theramed Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies
2. MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film
3. Core Essence Secures $11.5 Million Series B Financing
4. CardioFocus Secures $5M Credit Facility with Silicon Valley Bank
5. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
6. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
7. PLC Systems Secures $4 Million in Financing
8. Biomatrica Secures Strategic Investment from IQT
9. Digital Assent Secures $2 Million Series A Financing to Grow PatientPad Point-of-Care Network
10. TechniScan Secures $10 Million Equity Financing Facility
11. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... -- Intec Pharma Ltd. (NASDAQ: ... announced the appointment of Pnina Strauss-Levy as ... Strauss-Levy has 15 years of experience in clinical research ... record, having supported the advancement of several products through ... the United States and ...
(Date:5/3/2016)... , May 3, 2016 ... bekannt, dass sie einen entscheidenden Meilenstein durch ... Ein Aufruf zum Handeln, um Patientenresultate  bei ... trägt zu Fortschritten im Verständnis der Hepatischen ... ein Bewusstsein für Hepatische Enzephalopathie in der ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... Dave Newberry, broker/owner of Newberry ... Center (PICC) annual fundraiser luncheon on Friday, May 20. “We have raised over ... victims of drug abuse,” said Newberry. , PICC is a local Kent, WA, clinic ...
(Date:5/2/2016)... CO (PRWEB) , ... May 02, 2016 , ... It ... serve as the keynote speaker for five events throughout the month of May. , ... a number of national news outlets. He also frequently appears on the Science Channel’s ...
(Date:5/2/2016)... ... 02, 2016 , ... As directed by its board of directors during its ... support to allow certified nurse practitioners (CNP) to practice to the full scope of ... supervision for three years and 3,600 hours. , In addition, HAP supports CNPs who ...
(Date:5/2/2016)... ... ... Eating Recovery Center’s Insight Behavioral Health Center (ERC Insight) , a ... eating disorder program under a new name: Eating Recovery Center, Chicago (ERC Chicago). ERC ... , To celebrate, ERC Chicago will host a ribbon-cutting ceremony and open house on ...
(Date:5/2/2016)... ... 2016 , ... The National Resident Matching Program® (NRMP®) has ... Match”), the system through which U.S. and international medical school students and graduates ... placed in the 2016 Match, and 29,572 were filled when the matching algorithm ...
Breaking Medicine News(10 mins):